Publication

Article

Applied Clinical Trials

Applied Clinical Trials-06-01-2024
Volume33
Issue 6

Applied Clinical Trials June 2024 Issue (PDF)

Click the title above for a link to open the Applied Clinical Trials June 2024 issue in an interactive PDF format.

Download Issue PDF
Articles in this issue
Applied Clinical Trials June 2024 Issue (PDF)
Applied Clinical Trials June 2024 Issue (PDF)
Sustainability: More than Meets the Eye
Sustainability: More than Meets the Eye
Status Check: Science & Sustainability
Status Check: Science & Sustainability
Aligning Patient Burden with Planetary Burden
Aligning Patient Burden with Planetary Burden
Sustainability in Clinical Trials: Purposeful Digitalization is Key
Sustainability in Clinical Trials: Purposeful Digitalization is Key
In Focus: Amid Heightened Industry Rules on Sustainability, How are CROs Faring?
In Focus: Amid Heightened Industry Rules on Sustainability, How are CROs Faring?

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!
Related Videos
Related Content
Credit: Proxima Studio | stock.adobe.com. While BGM remains the regulatory gold standard, CGM is gaining ground in exploratory endpoints and safety monitoring
August 28th 2025

Beyond the Fingerstick: Navigating CGM and BGM Decisions in GLP-1 Clinical Trials

Karl McEvoy, PhD, and Aubrey Verna
ACT Brief Episode 6: Supreme Court Ruling, VK2735 Obesity Trial, and Padcev-Keytruda Survival Gains
August 28th 2025

ACT Brief Episode 6: Supreme Court Ruling, VK2735 Obesity Trial, and Padcev-Keytruda Survival Gains

Andy Studna, Senior Editor
Image Credit: Adobe Stock Images/Robin
August 28th 2025

Phase III NIMBLE Trial Demonstrates Cemdisiran Efficacy in Generalized Myasthenia Gravis

Andy Studna, Senior Editor
ACT Brief Episode 5: How Digital Twins and AI Are Reshaping Clinical Trials
August 28th 2025

ACT Brief Episode 5: How Digital Twins and AI Are Reshaping Clinical Trials

Andy Studna, Senior Editor
Credit: Dzmitry | stock.adobe.com. SMA can range from severe cases that develop during infancy to milder forms of the disease that manifest later in life.
August 28th 2025

Evrysdi Helps Presymptomatic Infants with Spinal Muscular Atrophy Sit, Stand, and Walk in Phase II Trial

Davy James
Phase I/II RAINFOL-01 Trial Results Lead to FDA Breakthrough Designation for Genmab’s Rina-S for Advanced Endometrial Cancer
August 28th 2025

Phase I/II RAINFOL-01 Trial Results Lead to FDA Breakthrough Designation for Genmab’s Rina-S for Advanced Endometrial Cancer

Don Tracy, Associate Editor
© 2025 MJH Life Sciences

All rights reserved.